Krognes Steve E.
SEC insider (Form 3/4/5 filer). CIK 0001666236. Director at Guardant Health, Inc. (GH) and 2 other issuers. 40 reported Form 4/5 transactions since Sep 2024; latest on Sep 16, 2026. Located in PALO ALTO, CA.
Companies Krognes Steve E. has filed insider reports for
- Guardant Health, Inc. (GH): Director
- PLIANT THERAPEUTICS, INC. (PLRX): Director
- Denali Therapeutics Inc. (DNLI): Director
Krognes Steve E.
CIK: 0001666236
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (40 total)
- Sep 16, 2026GH
Guardant Health, Inc.
SaleDirect1.1K shares at avg. $174.46$192K - Sep 16, 2026GH
Guardant Health, Inc.
SaleDirect3.3K shares at avg. $175.42$579K - Sep 16, 2026GH
Guardant Health, Inc.
SaleDirect1.3K shares at avg. $176.34$229K - Sep 16, 2026GH
Guardant Health, Inc.
SaleDirect971 shares at avg. $177.48$172K - Jun 30, 2026GH
Guardant Health, Inc.
ExerciseDirect155 shares- - Jun 17, 2026GH
Guardant Health, Inc.
ExerciseDirect4.2K shares- - Jun 17, 2026GH
Guardant Health, Inc.
AwardDirectRestricted Stock Units
2.7K shares- - Jun 11, 2026PLRX
PLIANT THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
70K shares- - Jun 4, 2026GH
Guardant Health, Inc.
SaleDirect9.3K shares at avg. $132.51$1.2M - Jun 3, 2026DNLI
Denali Therapeutics Inc.
AwardDirect6.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 16, 2026 |  GH Guardant Health, Inc. | Sale | 1,103 | $174.46 | $192,432 | Direct |
| Sep 16, 2026 | GH Guardant Health, Inc. | Sale | 3,300 | $175.42 | $578,888 | Direct |
| Sep 16, 2026 | GH Guardant Health, Inc. | Sale | 1,300 | $176.34 | $229,236 | Direct |
| Sep 16, 2026 | GH Guardant Health, Inc. | Sale | 971 | $177.48 | $172,330 | Direct |
| Jun 30, 2026 | GH Guardant Health, Inc. | Exercise | 155 | - | $0 | Direct |
| Jun 17, 2026 | GH Guardant Health, Inc. | Exercise | 4,203 | - | $0 | Direct |
| Jun 17, 2026 | GH Guardant Health, Inc. | Award Restricted Stock Units | 2,711 | - | - | Direct |
| Jun 11, 2026 |  PLRX PLIANT THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 70,000 | - | - | Direct |
| Jun 4, 2026 | GH Guardant Health, Inc. | Sale | 9,294 | $132.51 | $1,231,522 | Direct |
| Jun 3, 2026 |  DNLI Denali Therapeutics Inc. | Award | 6,408 | - | $0 | Direct |
1-10 of 40 transactions